BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jin FX, Wang Y, Li MN, Li RJ, Guo JT. Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice. World J Diabetes 2024; 15(8): 1764-1777 [PMID: 39192849 DOI: 10.4239/wjd.v15.i8.1764]
URL: https://www.wjgnet.com/1948-9358/full/v15/i8/1764.htm
Number Citing Articles
1
Ke-Xin Zhang, Cheng-Xia Kan, Yu-Qun Wang, Ning-Ning Hou, Xiao-Dong Sun. Intestinal glucagon-like peptide-1 in hypoglycemic counterregulation for type 1 diabetes managementWorld Journal of Diabetes 2024; 15(12): 2380-2383 doi: 10.4239/wjd.v15.i12.2380
2
Hyder O Mirghani. Glucagon-like peptide-1 agonists: Role of the gut in hypoglycemia unawareness, and the rationale in type 1 diabetesWorld Journal of Diabetes 2024; 15(11): 2167-2172 doi: 10.4239/wjd.v15.i11.2167
3
Manjunath Havalappa Dodamani, Juniali Hatwal, Akash Batta. Role of intestinal glucagon-like peptide-1 in impaired counter-regulatory responses to hypoglycemiaWorld Journal of Diabetes 2024; 15(12): 2394-2398 doi: 10.4239/wjd.v15.i12.2394
4
Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng. Role of intestinal glucagon-like peptide-1 in hypoglycemia response impairment in type 1 diabetesWorld Journal of Diabetes 2024; 15(11): 2237-2241 doi: 10.4239/wjd.v15.i11.2237